Breast Neoplasms: all 12,820 studies
Page 9 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral CrisisRecruitingNCT07203729Phase 2
- Nurturing Exercise Routine for Greater Improvement in Zest and Energy on EnhertuRecruitingNCT07203378Phase 2
- Holistic Acupuncture for Patients With Chemotherapy Induced NauseaRecruitingNCT07201194Not applicable
- MELIORA Virtual Coach Intervention for Breast Cancer PreventionRecruitingNCT07200427Not applicable
- Immune Adverse Events Registry in Onco-Hematologic Patients Treated With ImmunotherapyNot yet recruitingNCT07198958
- ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast CancerRecruitingNCT07198724Phase 1/2
- AI-Assisted Chemotherapy Side Effect ManagementRecruitingNCT07198581Not applicable
- A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer PatientsNot yet recruitingNCT07197697Phase 2
- Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer SurgeryNot yet recruitingNCT07197684Not applicable
- Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing ChemotherapyNot yet recruitingNCT07197320
- Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.RecruitingNCT07195344Phase 4
- Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast CancerRecruitingNCT07195227Phase 2
- Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast CancerRecruitingNCT07193394Phase 2
- ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted TherapiesRecruitingNCT07191730
- Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone TherapyNot yet recruitingNCT07190651
- Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)RecruitingNCT07190443Phase 3
- MELIORA Data Collection CampaignsRecruitingNCT07190066Not applicable
- Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast CancerRecruitingNCT07188246Phase 2
- Correlation Between COVID-19 and Radiation Pneumonitis in Breast CancerNot yet recruitingNCT07188116
- Identification of HER2-Positive Breast Cancer Molecular Characterization and SubtypesNot yet recruitingNCT07187752Not applicable
- Wearable Ultrasound Patch for Breast ImagingNot yet recruitingNCT07186491Not applicable
- EXoPERT EMERALD Clinical StudyRecruitingNCT07186296
- IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable TumorsNot yet recruitingNCT07185568Not applicable
- Neurocognitive and Psychological Impact of Chemotherapy in Breast Cancer Patients: A Prospective Observational StudyNot yet recruitingNCT07184749
- Acupuncture for Anxiety/Depression in Patients With Breast CancerNot yet recruitingNCT07183813Not applicable
- SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd TreatmentRecruitingNCT07182721Phase 2
- A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast CancerNot yet recruitingNCT07180914
- Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast CancerRecruitingNCT07180056
- Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast CancerRecruitingNCT07179809Not applicable
- Regional Radiotherapy Omission in Low-Risk Node Positive Breast CancerRecruitingNCT07179744
- Breast Reconstruction and RadiotherapyRecruitingNCT07178886
- NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast CancerNot yet recruitingNCT07178730Phase 3
- A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain MetastasesNot yet recruitingNCT07177950Phase 1/2
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)RecruitingNCT07174336Phase 3
- ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerRecruitingNCT07173751Phase 3
- Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)Not yet recruitingNCT07170631Not applicable
- A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsRecruitingNCT07169994Phase 1/2
- Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral NeuropathyNot yet recruitingNCT07169864Not applicable
- Digital Tool for Psychological Support in Women With Breast CancerNot yet recruitingNCT07169539Not applicable
- Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast CancerRecruitingNCT07166185
- Guided Meditation During Radiation Therapy for Breast and Gynecological MalignanciesRecruitingNCT07166042Phase 3
- Ribociclib for HR-positive HER2-negative Metastatic Breast CancerRecruitingNCT07164976Phase 1/2
- Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast CancerNot yet recruitingNCT07164872Not applicable
- A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 InhibitorsNot yet recruitingNCT07163481Phase 1
- Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer PatientsNot yet recruitingNCT07162519Not applicable
- Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer PatientsRecruitingNCT07162298Phase 2
- Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast CancerNot yet recruitingNCT07162259Phase 4
- Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast CancerNot yet recruitingNCT07161791Phase 1/2
- Clinical Validation of Sophia Genetics AssayNot yet recruitingNCT07160010
- A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerRecruitingNCT07159451Phase 2
- DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentRecruitingNCT07158164Phase 4
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
- Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid TumorsRecruitingNCT07156253Phase 1
- Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast CancerRecruitingNCT07154563
- Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral NeuropathyEnrolling by invitationNCT07151963Not applicable
- Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer PatientsRecruitingNCT07151911
- Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast CancerNot yet recruitingNCT07151586Phase 2
- Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast CancerRecruitingNCT07146295Not applicable
- Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized TrialNot yet recruitingNCT07146009Not applicable
- Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsRecruitingNCT07145255Phase 1/2
- Tape Application Protocol for Enhanced ScarsNot yet recruitingNCT07144046Not applicable
- WinQ : a Window of Opportunity Study With MitoQ in Breast CancerRecruitingNCT07142096Not applicable
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary SurgeryRecruitingNCT07140172Not applicable
- Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic ReviewsEnrolling by invitationNCT07140107Not applicable
- Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast CancerRecruitingNCT07137416Phase 1
- Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.Not yet recruitingNCT07136974Phase 2
- MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapyRecruitingNCT07136753
- Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After LumpectomyRecruitingNCT07135661Not applicable
- Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain MetastasesRecruitingNCT07134153Phase 1/2
- Evaluation of Serum IL-7 as a Biomarker in Breast CancerNot yet recruitingNCT07133685
- Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer SurvivorsRecruitingNCT07133087
- Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast CancerNot yet recruitingNCT07132502
- SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast CancerNot yet recruitingNCT07132242Phase 2
- Stress Reduction Through AcupunctureRecruitingNCT07132034Not applicable
- Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial IntelligenceRecruitingNCT07131735
- PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast CancerNot yet recruitingNCT07130344Not applicable
- Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast CancerNot yet recruitingNCT07130162
- SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant ResponseNot yet recruitingNCT07129187Phase 2
- Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based StudyRecruitingNCT07128030Not applicable
- ILR to Prevent BRCL_MCC 23608RecruitingNCT07127003Not applicable
- DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal FailureNot yet recruitingNCT07124403
- Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO StudyRecruitingNCT07123649Phase 2
- Definitive Radiation Therapy for Inoperable Breast CancerRecruitingNCT07122713Not applicable
- Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.RecruitingNCT07120087Not applicable
- Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast CancerRecruitingNCT07117864Not applicable
- An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard TherapyRecruitingNCT07117630Phase 2
- A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung CancersRecruitingNCT07117214Phase 1
- Comparing Patient Reported Outcomes and Clinical Outcomes Based on Different Scar Placement in Patients Undergoing Standard Breast Conserving Surgery for Breast Cancer: The PROM-S Study.RecruitingNCT07116642
- Molecular Breast Imaging (MBI)-Guided BiopsyNot yet recruitingNCT07114679Not applicable
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
- Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant TherapyRecruitingNCT07113613Phase 2
- Role of FGF21 in Breast CancerNot yet recruitingNCT07113418
- Intraoperative Margin Assessment in Breast Cancer With HSI-RamanRecruitingNCT07111728
- Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast CancerRecruitingNCT07109817Phase 2
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruitingNCT07109726Phase 1/2
- A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-GrowthRecruitingNCT07108517Not applicable
- Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer PatientsRecruitingNCT07107594Not applicable
- Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast CancerNot yet recruitingNCT07107217Phase 2
- Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic TestsRecruitingNCT07106632Phase 3
- Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant TherapyRecruitingNCT07106112Not applicable